Meet Our Management Team

Together, they are furthering NuView Life Science’s mission: to change the way many types of cancer are diagnosed and treated using precision medicine technology. Diagnosing and treating cancer with a targeted, specific approach to the disease will help to increase positive patient outcomes while also driving down costs incurred by patients, healthcare providers, and third-party insurance payers.

PAUL J. CROWE

Chairman and CEO

Mr. Crowe founded NuView Life Sciences in 2005 and serves as its Chairman and Chief Executive Officer. Mr. Crowe’s experience includes start-up and early-stage healthcare company development, strategic planning, capital formation, M&A, and public offerings. Mr. Crowe’s career includes senior executive sales and management positions for domestic and multi-national healthcare companies who introduced (a) diagnostic ultrasound in 1973 for Rohe Ultrasound – NV Philips Medical Systems; (b) nuclear magnetic resonance (NMR / MRI) in 1983 for Diasonics NMR Inc.; and (c) mobile positron emission tomography (PET) in 1999 for Mobile P.E.T. Systems Inc., Between 1986 and 1999 Mr. Crowe developed and operated outpatient medical service provider businesses, including diagnostic imaging facilities and gamma knife radio surgery facilities, and currently serves on the Board of Radiosurgical Centers of San Diego located at Scripps Memorial Hospital.

JAY BISHOFF, MD

Chief Medical Officer

Jay Bishoff, MD is the Director of the Intermountain Urological Institute and Director of Robotics. He is a Johns Hopkins fellowship trained surgeon, who serves urology patients, and their families, using best practice guidelines, his measured experience and the least invasive means possible. The training he has received over the past eight years at Intermountain Health Care, has ignited within him a passion for quality improvement and given him a skill set to develop programs that improve patient outcomes, while significantly reducing the cost of health care.

Jill Helmke, D.Ph,N.Ph.

Director of Clinical Trials / Chief Pharmacy Officer (CPO)

Jill S. Helmke, Certified Nuclear Pharmacist and Doctor of Pharmacy, comes to NuView Life Sciences, with over 25 years of pharmacy experience ranging from outpatient pharmacy to clinical research. A graduate of The Ohio State University, she also completed a specialty in Nuclear Medicine. In addition, she has degrees in Business Management and Music from Baldwin Wallace University. Dr. Helmke practiced nuclear medicine for 15 years at Cardinal Health and Vanderbilt University Medical Center, specializing in Positron Emission Tomography (PET). While at Vanderbilt, she branched into Biomedical Informatics wherein she focused on pediatric drug formulations, as well as compounding research and development. A major contributor to STEPStools (Safety through Electronic Prescribing System Tools), Dr. Helmke presented her research to the American Academy of Pediatrics in Washington D.C. and has received national recognition for her efforts in Biomedical Informatics. After relocating to Park City, UT, Dr. Helmke continued her Biomedical Informatics research with the University of Utah. Subsequently, she conducted Phase I-IV clinical drug trials with PRA Health Sciences.

THOMAS BROWN

Chief Financial Officer

Mr. Brown has over 40 years of business and financial experience in the analysis, structuring and sourcing of capital, valuation, repositioning/restructuring and the management of financial/operating assets as well as businesses. Mr. Brown is the founding partner of three investment banking firms, a private equity firm and an investment management firm. Mr. Brown has served as the CFO of several public and private companies as well as non-profit organizations focused on coordinating the reporting and management of the financial infrastructure of emerging growth ventures and organizations. In addition to serving on the board of several public, private and non-profit organizations, Mr. Brown has been the chairman of the audit committees of several public companies. Mr. Brown graduated from the University of Southern California with a B.S. in Finance and earned the Chartered Financial Analyst (CFA) designation.

WILLIAM J. BROCK

Investor Relations

Bill Brock is the founder and CEO of Iron Rock, LLC, a diversified financial services company that for over 10 years has focused on capital raising for companies and a select group of private equity and hedge funds.
Mr. Brock is a cum laude graduate of Harvard College (BA) and has a master’s in business administration (MBA) from The Harvard Business School.
His career of over 35 years in financial services began with investment banking at Merrill Lynch and subsequently led to executive positions at First Boston and Goldman Sachs. In addition to investment banking, Mr. Brock held senior positions in the fixed income capital markets department and was the global head of the medium-term note product area. While holding these positions, Mr. Brock had extensive interaction with Fortune 500 companies and major corporate and sovereign entities in Europe and Asia. He also headed a fixed income derivative desk at Salomon Brothers.
Mr. Brock has also been the president of an internet company focused on the middle market merger and acquisitions business and founded a leverage buyout firm which successfully invested in a portfolio of middle market industrial companies. He also served as the President of a financial company focused on advising and providing growth capital for wealth managers. These managers had more than $2 billion in Assets Under Management.
Over his career he has transacted billions of dollars of transactions for hundreds of companies domestically and internationally.
Mr. Brock has served as a director on several public company boards
Mr. Brock holds Series 7 and 63 licenses.